Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Salting-out-assisted liquid-liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples

K. Hajkova, B. Jurasek, D. Sykora, T. Palenicek, P. Miksatkova, M. Kuchar,

. 2016 ; 408 (4) : 1171-81. [pub] 20151211

Language English Country Germany

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK ProQuest Central from 2011-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2003-01-01 to 1 year ago
Health & Medicine (ProQuest) from 2011-01-01 to 1 year ago

A new designer drug, a dissociative anesthetic, and a putative N-methyl-D-aspartate receptor antagonist, methoxetamine (MXE) noted by the EU Early Warning System has been already identified as a cause of several fatalities worldwide. The primary objective of this work was to develop a suitable sample preparation method allowing for isolation of MXE and its main metabolites in high yields from rat brain, liver, and lungs. For the purpose of the project, MXE and five metabolites were synthesized in-house, specifically O-desmethyl-normethoxetamine, O-desmethylmethoxetamine, dihydro-O-desmethylmethoxetamine, normethoxetamine, and dihydromethoxetamine. A sample preparation procedure consisted in the homogenization of the tissue applying salting-out-assisted liquid-liquid extraction (SALLE). A subsequent liquid chromatography-mass spectrometry (LC-MS) analysis was based on reversed-phased chromatography hyphenated with a triple quad MS system in a positive electrospray mode. Multiple reaction monitoring (MRM) was used for qualification and quantification of the analytes. The quantification was based on the application of an isotopically labeled internal standard, normethoxetamine-d3. The matrix-matched calibrations were prepared for each type of matrix with regression coefficients 0.9943-1.0000. The calibration curves were linear in the concentration range of 2.5-250 ng g(-1). Limits of quantification (LOQs) were estimated as 2.5 and 5 ng g(-1), respectively. Recovery (80-117%) and matrix effect (94-110%) at 100 ng g(-1) and intra- and inter-day accuracy and precision at low (2.5 ng g(-1)), middle (25 ng g(-1)), and upper (250 ng g(-1)) concentration levels for all the analytes in all three types of tissues were also determined. The developed analytical method was applied to a set of real samples gathered in toxicological trials on rats and MXE, and its metabolites were determined successfully.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000779
003      
CZ-PrNML
005      
20170113102616.0
007      
ta
008      
170103s2016 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00216-015-9221-1 $2 doi
024    7_
$a 10.1007/s00216-015-9221-1 $2 doi
035    __
$a (PubMed)26661068
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Hajkova, Katerina $u Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic. Department of Analytical Chemistry, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic. National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
245    10
$a Salting-out-assisted liquid-liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples / $c K. Hajkova, B. Jurasek, D. Sykora, T. Palenicek, P. Miksatkova, M. Kuchar,
520    9_
$a A new designer drug, a dissociative anesthetic, and a putative N-methyl-D-aspartate receptor antagonist, methoxetamine (MXE) noted by the EU Early Warning System has been already identified as a cause of several fatalities worldwide. The primary objective of this work was to develop a suitable sample preparation method allowing for isolation of MXE and its main metabolites in high yields from rat brain, liver, and lungs. For the purpose of the project, MXE and five metabolites were synthesized in-house, specifically O-desmethyl-normethoxetamine, O-desmethylmethoxetamine, dihydro-O-desmethylmethoxetamine, normethoxetamine, and dihydromethoxetamine. A sample preparation procedure consisted in the homogenization of the tissue applying salting-out-assisted liquid-liquid extraction (SALLE). A subsequent liquid chromatography-mass spectrometry (LC-MS) analysis was based on reversed-phased chromatography hyphenated with a triple quad MS system in a positive electrospray mode. Multiple reaction monitoring (MRM) was used for qualification and quantification of the analytes. The quantification was based on the application of an isotopically labeled internal standard, normethoxetamine-d3. The matrix-matched calibrations were prepared for each type of matrix with regression coefficients 0.9943-1.0000. The calibration curves were linear in the concentration range of 2.5-250 ng g(-1). Limits of quantification (LOQs) were estimated as 2.5 and 5 ng g(-1), respectively. Recovery (80-117%) and matrix effect (94-110%) at 100 ng g(-1) and intra- and inter-day accuracy and precision at low (2.5 ng g(-1)), middle (25 ng g(-1)), and upper (250 ng g(-1)) concentration levels for all the analytes in all three types of tissues were also determined. The developed analytical method was applied to a set of real samples gathered in toxicological trials on rats and MXE, and its metabolites were determined successfully.
650    _2
$a zvířata $7 D000818
650    _2
$a mozek - chemie $7 D001923
650    _2
$a kalibrace $7 D002138
650    _2
$a chromatografie kapalinová $x metody $7 D002853
650    _2
$a cyklohexanony $x analýza $x metabolismus $x farmakokinetika $7 D003512
650    _2
$a cyklohexylaminy $x analýza $x metabolismus $x farmakokinetika $7 D003514
650    _2
$a nové syntetické drogy $x analýza $7 D015198
650    _2
$a limita detekce $7 D057230
650    _2
$a extrakce kapalina-kapalina $x metody $7 D059625
650    _2
$a játra $x chemie $7 D008099
650    _2
$a plíce $x chemie $7 D008168
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a tandemová hmotnostní spektrometrie $x metody $7 D053719
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Jurasek, Bronislav $u Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic.
700    1_
$a Sykora, David $u Department of Analytical Chemistry, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic. david.sykora@vscht.cz.
700    1_
$a Palenicek, Tomas $u National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
700    1_
$a Miksatkova, Petra $u Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic. National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
700    1_
$a Kuchar, Martin $u Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic. National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
773    0_
$w MED00006638 $t Analytical and bioanalytical chemistry $x 1618-2650 $g Roč. 408, č. 4 (2016), s. 1171-81
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26661068 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170113102716 $b ABA008
999    __
$a ok $b bmc $g 1179919 $s 961346
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 408 $c 4 $d 1171-81 $e 20151211 $i 1618-2650 $m Analytical and bioanalytical chemistry $n Anal Bioanal Chem $x MED00006638
LZP    __
$a Pubmed-20170103

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...